Hamilton Morris (born April 14, 1987) is an American journalist, documentarian, and scientific researcher. He is the creator and director of the television series Hamilton's Pharmacopeia, in which he investigated the chemistry, history, and cultural impact of various psychoactive drugs. In September 2021, Morris left Vice to work as a chemistry consultant at the biotechnology startup, Compass Pathways.[1]
Hamilton Morris | |
|---|---|
 | |
| Born | Hamilton Morris April 14, 1987 New York City, U.S. |
| Alma mater | The University of Chicago The New School (BSc) |
| Occupation(s) | Journalist, researcher |
| Known for | Hamilton's Pharmacopeia |
Biography
editHamilton Morris was born in New York City, the son of Julia Sheehan, an art historian, and documentary filmmaker Errol Morris.[2][3] He was raised in Cambridge, Massachusetts. As a teenager, Morris appeared in television commercials, notably a 2002 advertisement for the first-generation iPod.[4] He attended the University of Chicago and The New School, where he studied anthropology and chemistry.[5][6]
Morris's interest in psychoactive substances blossomed in his late teens when he began reading pharmacology information hosted on websites such as Bluelight and Erowid.[7] He began writing for Vice magazine as a college sophomore. He wrote a piece called 'The Magic Jews' in 2008 documenting his experience taking LSD with a group of Hasidic Jews.[8][9] Vice later hired him to write a monthly print column titled "Hamilton's Pharmacopeia" that evolved into a series of articles and documentaries for VBS.tv focused on the science of psychoactive drugs.[2]
Morris was a correspondent and producer for Vice on HBO until 2021, and is a contributor to Harper's Magazine.[10] Morris frequently consults with media on the subject of psychoactive drugs and conducts pharmacological research at Saint Joseph's University in Philadelphia[2][11][12] with an emphasis on the synthesis and history of dissociative anesthetics.[13][14][15][16]
Morris has coauthored scientific papers on hallucinogens, including a 2014 review on dissociatives[13] and a major 2023 study identifying serotonergic psychedelics as mediating their hallucinogenic effects via activation of the serotonin 5-HT2A receptor Gq signaling pathway.[17]
Projects
editVideo
edit- The Sapo Diary: Phyllomedusa bicolor skin secretions in Amazonia
- Nzambi: Wade Davis's theory of TTX-mediated zombification in Haiti
- High on Krystle: An exploration of the clandestine laboratory once operated by William Leonard Pickard
- SiHKAL: Shulgins I Have Known and Loved (with Alexander Shulgin & Ann Shulgin)
- The Icelandic Skin Disease Mushroom Fiasco
- Hamilton Morris and the Philosopher's Stone: Psilocybin-containing sclerotium laboratories in The Netherlands
- Tanks for the Memories: An exploration of sensory deprivation tanks with Joe Rogan
- The Ambien Effect
- Swaziland: Gold Mine of Marijuana
- Efavirenz as a classical psychedelic
- Chinese synthetic cannabinoid laboratories
- Businesses involved in the ongoing legalization of Cannabis in the United States
Hamilton's Pharmacopeia, Viceland
editSEASON 1
- The Story of the South African Quaalude
- A Positive PCP Story
- Shepherdess: The Story of Salvia Divinorum
- Magic Mushrooms in Mexico
- Fish n' Trips
- The Lazy Lizard School of Hedonism
SEASON 2
- The Psychedelic Toad
- Peyote: The Divine Messenger
- Kratom: The Forbidden Leaf
- Wizards of DMT
- Ketamine: Realms and Realities
- A Clandestine Chemist's Tale
- A Fungal Fairy Tale
- The Cactus Apprentice
SEASON 3
- Synthetic Toad Venom Machine
- A Positive Methamphetamine Story
- Xenon: The Perfect Anesthetic?
- Synthetic Ibogaine-Natural Tramadol
- Bufotenine: In Search of Hataj
- Ultra LSD[18]
Podcast
editSee also
editReferences
edit- ^ Hausfeld, Russel; Nickles, David (September 22, 2021). "Hamilton Morris Hired by Psilocybin Startup COMPASS Pathways, Ends "Hamilton's Pharmacopeia" On Vice".
- ^ a b c Green, Penelope (June 10, 2015). "Nesting, the Vice Media Way". The New York Times. Retrieved July 10, 2015.
- ^ Eric Andre talks with Hamilton Morris, January 13, 2021, retrieved June 25, 2021
- ^ "Hamilton Morris – Apple iPod Switch Campaign". YouTube. Switch (ad campaign). 2002. Retrieved June 20, 2021.
- ^ Perlstein, Rick (September 23, 2007). "What's the Matter With College?". The New York Times. Retrieved July 10, 2015.
- ^ Simonini, Ross (February 10, 2012). "Hamilton Morris's Web Series Hamilton's Pharmacopeia". The New York Times. Retrieved July 10, 2015.
- ^ Simonini, Ross (February 10, 2012). "A Psychonaut's Adventures in Videoland". The New York Times. ISSN 0362-4331. Retrieved March 19, 2024.
- ^ Margolin, Madison (November 27, 2023). "The Magic Jews". Tablet. Retrieved March 18, 2024.
- ^ Williamson, Hamilton Morris; Photos: Jess (September 2, 2008). "The Magic Jews". Vice. Retrieved March 19, 2024.
{{cite web}}: CS1 maint: multiple names: authors list (link) - ^ Morris, Hamilton (September 20, 2012). "The Weird Science Issue". Vice Magazine. Retrieved July 10, 2015.
- ^ Halford, Bethany (April 10, 2015). "A Glimpse Inside The Sophisticated World of Synthetic Cannabinoids". Chemical & Engineering News. Retrieved July 10, 2015.
- ^ Grigoriadis, Vanessa (April 7, 2013). "Travels in the New Psychedelic Bazaar". New York. Retrieved July 10, 2015.
- ^ a b Morris, H.; Wallach, J. (2014). "From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs". Drug Testing and Analysis. 6 (7–8): 614–32. doi:10.1002/dta.1620. PMID 24678061.
- ^ Elliott, S.P.; Brandt, S.D.; Wallach, J.; Morris, H.; Kavanagh, S. (2015). "First Reported Fatalities Associated with the 'Research Chemical' 2-Methoxydiphenidine". Analytical Toxicology. 39 (4): 287–293. doi:10.1093/jat/bkv006. PMID 25698777.
- ^ McLaughlin, G.; Morris, N.; Kavanagh, P.; Power, J.; O'Brien, J.; Talbot, B.; Elliott, S.; Wallach, J.; Hoang, K.; Morris, H.; Brandt, S. (2015). "Test purchase, synthesis, and characterization of 2-methoxydiphenidine (MXP) and differentiation from its meta- and para-substituted isomers" (PDF). Drug Testing and Analysis. 8 (1): 98–109. doi:10.1002/dta.1800. PMID 25873326. S2CID 33626099.
- ^ Wallach, J.; Kavanagh, P.; McLaughlin, G.; Morris, N.; Power, J.; Elliott, S.; Mercier, M.; Lodge, D.; Morris, H.; Dempster, N.; Brandt, S. (2014). "Preparation and characterization of the 'research chemical' diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers" (PDF). Drug Testing and Analysis. 7 (5): 358–67. doi:10.1002/dta.1689. PMID 25044512.
- ^ Wallach J, Cao AB, Calkins MM, Heim AJ, Lanham JK, Bonniwell EM, Hennessey JJ, Bock HA, Anderson EI, Sherwood AM, Morris H, de Klein R, Klein AK, Cuccurazzu B, Gamrat J, Fannana T, Zauhar R, Halberstadt AL, McCorvy JD (December 2023). "Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential". Nat Commun. 14 (1): 8221. doi:10.1038/s41467-023-44016-1. PMC 10724237. PMID 38102107.
- ^ "'Pharmacopeia' Season Finale Features Cutting Edge Psychedelic Research". Psychedelic Science Review. February 9, 2021. Retrieved February 11, 2021.
- ^ "The Hamilton Morris Podcast". Buzzsprout. Retrieved November 15, 2022.
- ^ "Hamilton Morris is creating Science, Film". Patreon. Retrieved November 15, 2022.